Overview

Clinical Trial Study About Human Adipose-Derived Stem Cells in the Stroke

Status:
Completed
Trial end date:
2018-11-27
Target enrollment:
Participant gender:
Summary
The objective of the study is to confirm the safety and possible efficacy of Adipose-Tissue Derived Stem Cells treatment of chronic stroke. Specifically, the study will transplant autologous ADSCs into brain surrounding ischemic infarct in adult (65-80 years old) subjects who have chronic non-hemorrhagic stroke (>6 months).
Phase:
Phase 1
Details
Lead Sponsor:
Gwo Xi Stem Cell Applied Technology Co., Ltd.